Preferred Name |
Sulfasalazine |
|
Synonyms |
Sulfasalazine 2-Hydroxy-5-[[4-[(2-pyridinylamino)sulfonyl]phenyl]azo]benzoic Acid Sulphasalazine Salazosulfapyridine SULFASALAZINE Azulfidine |
|
Definitions |
A synthetic salicylic acid derivative with affinity for connective tissues containing elastin and formulated as a prodrug, antiinflammatory Sulfasalazine acts locally in the intestine through its active metabolites, sulfamide 5-aminosalicylic acid and salicylic acid, by a mechanism that is not clear. It appears inhibit cyclooxygenase and prostaglandin production and is used in the management of inflammatory bowel diseases. (NCI04) |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C29469 |
|
CAS_Registry |
599-79-1 |
|
CHEBI_ID |
CHEBI:9334 |
|
Chemical_Formula |
C18H14N4O5S |
|
code |
C29469 |
|
Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978 |
|
Contributing_Source |
CTRP FDA |
|
DEFINITION |
A synthetic salicylic acid derivative with affinity for connective tissues containing elastin and formulated as a prodrug, antiinflammatory Sulfasalazine acts locally in the intestine through its active metabolites, sulfamide 5-aminosalicylic acid and salicylic acid, by a mechanism that is not clear. It appears inhibit cyclooxygenase and prostaglandin production and is used in the management of inflammatory bowel diseases. (NCI04) |
|
Display_Name |
Sulfasalazine |
|
FDA_UNII_Code |
3XC8GUZ6CB |
|
FULL_SYN |
Sulfasalazine 2-Hydroxy-5-[[4-[(2-pyridinylamino)sulfonyl]phenyl]azo]benzoic Acid Sulphasalazine Salazosulfapyridine SULFASALAZINE Azulfidine |
|
label |
Sulfasalazine |
|
Legacy Concept Name |
Sulfasalazine |
|
NCI_Drug_Dictionary_ID |
685032 |
|
NSC Number |
203730 667219 |
|
PDQ_Closed_Trial_Search_ID |
685032 |
|
PDQ_Open_Trial_Search_ID |
685032 |
|
Preferred_Name |
Sulfasalazine |
|
prefixIRI |
Thesaurus:C29469 |
|
Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
UMLS_CUI |
C0036078 |
|
subClassOf |